# Broadfin Capital

Broadfin Capital is an Asset Manager based in New York, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2005
- **Assets under management:** Undisclosed
- **Website:** broadfincapital.com
- **LinkedIn:** https://www.linkedin.com/company/broadfin-capital

## Regulatory record

- **Reports private funds:** No

## About

Broadfin Capital is a global equity healthcare manager based in Melville, New York. Founded in 2005, the company focuses on the healthcare sector and employs a value-oriented investment strategy based on fundamental research. It invests in medical technology, pharmaceuticals, and biotechnology sectors across all market capitalizations, managing binary event risks.

## Sectors

- Healthcare Services
- Biotechnology
- Medical Devices
- Pharmaceuticals

## Offices

- San Francisco, CA
- Boston, MA

## People

- Kevin Kotler — Founder & Portfolio Manager

## Questions

### Who made investment decisions at Broadfin Capital?

Kevin Kotler, the founder, served as the sole portfolio manager and made all final investment decisions. He built the firm after working as a healthcare analyst and maintained a flat structure without co-portfolio managers, which kept decision-making concentrated and fast.

### What was Broadfin's most notable investment?

Auspex Pharmaceuticals was Broadfin's signature win. The firm built an 8.4% stake at an average cost around $15 per share and realized over $150 million when Teva Pharmaceutical Industries acquired Auspex for $101 per share in cash in 2015, a return exceeding 10x.

## Related profiles

- [Convex Group Limited](https://altss.com/profile/convex-group-limited)
- [RK Pharma](https://altss.com/profile/rk-pharma-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/broadfin-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology